RASSF1A and CDH1 hypermethylation as potential epimarkers in breast cancer.
Sebova K, Zmetakova I, Bella V, Kajo K, Stankovicova I, Kajabova V, Krivulcik T, Lasabova Z, Tomka M, Galbavy S, Fridrichova I.
Sebova K, et al. Among authors: galbavy s.
Cancer Biomark. 2011-2012;10(1):13-26. doi: 10.3233/CBM-2012-0230.
Cancer Biomark. 2011.
PMID: 22297548